Financing Round Led by OrbiMed with participation from Lumira Ventures, Harrington Discovery Institute and existing investors Advent Life Sciences and Belinda Termeer Therapy development focused on addressing a fundamental mechanism… Read More
DUBLIN, IE and VANCOUVER, BC — Jazz Pharmaceuticals plc (Nasdaq: JAZZ) and Zymeworks Inc. (NYSE: ZYME) today announced that Jazz and Zymeworks’ subsidiary, Zymeworks BC Inc., have entered into an exclusive licensing agreement… Read More
VANCOUVER, BC – PrecisionOS has announced a collaboration with Massachusetts General Hospital (MGH) to augment the Combined Orthopedic Residency Program (CORP) with immersive Virtual Reality (VR) training. Faculty members of MGH/CORP will… Read More
Surgical site infections reduced by an average of 47% across all surgery types (P=0.01). Most significant impact seen in cardiac surgeries – almost 70% reduction (P=0.02). Mortality rate cut by… Read More
Evusheld is the first long-acting antibody (LAAB) combination to receive Health Canada authorization for both the prevention and treatment of COVID-19 Evusheld significantly reduced risk of severe COVID-19 or death in… Read More
